Published in Philos Trans R Soc Lond B Biol Sci on December 05, 2012
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. Inflammopharmacology (2013) 1.61
Focal brain inflammation and autism. J Neuroinflammation (2013) 1.03
Mast cells, glia and neuroinflammation: partners in crime? Immunology (2014) 0.99
Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philos Trans R Soc Lond B Biol Sci (2012) 0.96
Palmitoylethanolamide, a naturally occurring lipid, is an orally effective intestinal anti-inflammatory agent. Br J Pharmacol (2014) 0.86
Treatment of chronic regional pain syndrome type 1 with palmitoylethanolamide and topical ketamine cream: modulation of nonneuronal cells. J Pain Res (2013) 0.85
Mast cell-nerve cell interaction at acupoint: modeling mechanotransduction pathway induced by acupuncture. Int J Biol Sci (2014) 0.82
Dopaminergic Toxin 1-Methyl-4-Phenylpyridinium, Proteins α-Synuclein and Glia Maturation Factor Activate Mast Cells and Release Inflammatory Mediators. PLoS One (2015) 0.77
Palmitoylethanolamide, a neutraceutical, in nerve compression syndromes: efficacy and safety in sciatic pain and carpal tunnel syndrome. J Pain Res (2015) 0.76
Co-ultramicronized Palmitoylethanolamide/Luteolin Promotes the Maturation of Oligodendrocyte Precursor Cells. Sci Rep (2015) 0.76
Co-ultramicronized Palmitoylethanolamide/Luteolin in the Treatment of Cerebral Ischemia: from Rodent to Man. Transl Stroke Res (2015) 0.76
Glial Modulation by N-acylethanolamides in Brain Injury and Neurodegeneration. Front Aging Neurosci (2016) 0.75
Expression and Differential Responsiveness of Central Nervous System Glial Cell Populations to the Acute Phase Protein Serum Amyloid A. Sci Rep (2017) 0.75
Intracisternal injection of palmitoylethanolamide inhibits the peripheral nociceptive evoked responses of dorsal horn wide dynamic range neurons. J Neural Transm (Vienna) (2014) 0.75
Immune-mediated processes in neurodegeneration: where do we stand? J Neurol (2016) 0.75
Brain and Peripheral Atypical Inflammatory Mediators Potentiate Neuroinflammation and Neurodegeneration. Front Cell Neurosci (2017) 0.75
Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat Neurosci (2007) 11.11
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides. Nature (1996) 8.99
Physiology of microglia. Physiol Rev (2011) 6.99
The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev (2006) 6.80
Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat Med (2006) 6.15
Ccr2 deficiency impairs microglial accumulation and accelerates progression of Alzheimer-like disease. Nat Med (2007) 5.87
The inflammatory response in stroke. J Neuroimmunol (2006) 5.33
Mast cells in the development of adaptive immune responses. Nat Immunol (2005) 4.96
Control of pain initiation by endogenous cannabinoids. Nature (1998) 4.73
Myelin-associated inhibitors of axonal regeneration in the adult mammalian CNS. Nat Rev Neurosci (2003) 4.60
Experimental autoimmune encephalomyelitis repressed by microglial paralysis. Nat Med (2005) 4.42
Immune function of astrocytes. Glia (2001) 4.05
Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain. J Neurosci (2007) 3.93
MAP kinase and pain. Brain Res Rev (2008) 3.75
Microglial interactions with synapses are modulated by visual experience. PLoS Biol (2010) 3.59
The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A (2005) 3.59
Repertoire of microglial and macrophage responses after spinal cord injury. Nat Rev Neurosci (2011) 3.40
The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol Pharmacol (2004) 3.38
Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain. Pain (2005) 3.37
The role of neuroinflammation and neuroimmune activation in persistent pain. Pain (2001) 3.15
Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils. J Clin Invest (1986) 2.90
Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses. Brain Behav Immun (2006) 2.89
Formation and maintenance of Alzheimer's disease beta-amyloid plaques in the absence of microglia. Nat Neurosci (2009) 2.85
Molecular characterization of a phospholipase D generating anandamide and its congeners. J Biol Chem (2003) 2.75
Microglia in health and disease. J Neurosci Res (2005) 2.74
Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis. J Exp Med (2000) 2.54
Suppression of experimental allergic encephalomyelitis in Lewis rats after elimination of macrophages. J Exp Med (1990) 2.42
The many faces of tumor necrosis factor in stroke. Nat Med (2002) 2.33
Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide. Proc Natl Acad Sci U S A (1995) 2.33
Computational identification of gene-social environment interaction at the human IL6 locus. Proc Natl Acad Sci U S A (2010) 2.31
Cell-to-cell spread of calcium signals mediated by ATP receptors in mast cells. Nature (1992) 2.29
Chemokines, neuronal-glial interactions, and central processing of neuropathic pain. Pharmacol Ther (2010) 2.27
The microglial "activation" continuum: from innate to adaptive responses. J Neuroinflammation (2005) 2.23
Identification of mast cell progenitors in adult mice. Proc Natl Acad Sci U S A (2005) 2.19
β-Adrenergic receptor antagonism prevents anxiety-like behavior and microglial reactivity induced by repeated social defeat. J Neurosci (2011) 2.15
A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity. J Biol Chem (2007) 2.05
Activation of mast cells by double-stranded RNA: evidence for activation through Toll-like receptor 3. J Allergy Clin Immunol (2004) 2.02
Mast cells synthesize, store, and release nerve growth factor. Proc Natl Acad Sci U S A (1994) 1.97
The ALIAmide palmitoylethanolamide and cannabinoids, but not anandamide, are protective in a delayed postglutamate paradigm of excitotoxic death in cerebellar granule neurons. Proc Natl Acad Sci U S A (1996) 1.84
Glial proinflammatory cytokines mediate exaggerated pain states: implications for clinical pain. Adv Exp Med Biol (2003) 1.84
Purinergic signalling: from normal behaviour to pathological brain function. Prog Neurobiol (2011) 1.76
Microglia and macrophages are the major source of tumor necrosis factor in permanent middle cerebral artery occlusion in mice. J Cereb Blood Flow Metab (2000) 1.74
P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J Neurosci (2008) 1.74
Nerve growth factor: from neurotrophin to neurokine. Trends Neurosci (1996) 1.70
Selective N-acylethanolamine-hydrolyzing acid amidase inhibition reveals a key role for endogenous palmitoylethanolamide in inflammation. Proc Natl Acad Sci U S A (2009) 1.64
N-(2-hydroxyethyl)hexadecanamide is orally active in reducing edema formation and inflammatory hyperalgesia by down-modulating mast cell activation. Eur J Pharmacol (1996) 1.61
Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J Biol Chem (2001) 1.57
Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis (2005) 1.57
Bi-directional immune-brain communication: Implications for understanding stress, pain, and cognition. Brain Behav Immun (2003) 1.56
P2Y12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J Neurosci (2008) 1.55
Identification of a microglia phenotype supportive of remyelination. Glia (2011) 1.51
Spinal cord glia: new players in pain. Pain (2001) 1.51
Minocycline reduces microglial activation and improves behavioral deficits in a transgenic model of cerebral microvascular amyloid. J Neurosci (2007) 1.50
Palmitoylethanolamide increases after focal cerebral ischemia and potentiates microglial cell motility. J Neurosci (2003) 1.49
Neuroprotective function for ramified microglia in hippocampal excitotoxicity. J Neuroinflammation (2012) 1.49
Chronic stress alters the density and morphology of microglia in a subset of stress-responsive brain regions. Brain Behav Immun (2010) 1.49
Antinociceptive activity of the endogenous fatty acid amide, palmitylethanolamide. Eur J Pharmacol (2001) 1.45
Endocannabinoids control spasticity in a multiple sclerosis model. FASEB J (2000) 1.44
Expression of the receptor for complement C5a (CD88) is up-regulated on reactive astrocytes, microglia, and endothelial cells in the inflamed human central nervous system. Am J Pathol (1997) 1.41
Neuronal and microglial mechanisms of neuropathic pain. Mol Brain (2011) 1.41
Protection from Alzheimer's-like disease in the mouse by genetic ablation of inducible nitric oxide synthase. J Exp Med (2005) 1.40
Antiinflammatory action of endocannabinoid palmitoylethanolamide and the synthetic cannabinoid nabilone in a model of acute inflammation in the rat. Br J Pharmacol (2002) 1.40
CX3CR1 protein signaling modulates microglial activation and protects against plaque-independent cognitive deficits in a mouse model of Alzheimer disease. J Biol Chem (2011) 1.40
Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet (2007) 1.40
Mast cells exert effects outside the central nervous system to influence experimental allergic encephalomyelitis disease course. J Immunol (2003) 1.39
Glia as a therapeutic target: selective suppression of human amyloid-beta-induced upregulation of brain proinflammatory cytokine production attenuates neurodegeneration. J Neurosci (2006) 1.39
Macrophages and inflammation in the central nervous system. Trends Neurosci (1993) 1.36
Neuroprotective effect of exogenous microglia in global brain ischemia. J Cereb Blood Flow Metab (2006) 1.35
Toll-like receptor 2 (TLR2) and TLR4 differentially activate human mast cells. Eur J Immunol (2003) 1.35
Mast cells migrate from blood to brain. J Neurosci (2000) 1.34
Acute stress increases permeability of the blood-brain-barrier through activation of brain mast cells. Brain Res (2001) 1.34
BDNF and gp145trkB in multiple sclerosis brain lesions: neuroprotective interactions between immune and neuronal cells? Brain (2002) 1.33
Glial cells and chronic pain. Neuroscientist (2010) 1.32
Chronic stress induces transient spinal neuroinflammation, triggering sensory hypersensitivity and long-lasting anxiety-induced hyperalgesia. Pain (2010) 1.32
Mast cells in the brain: evidence and functional significance. Trends Neurosci (1996) 1.31
The microglial-motoneuron dialogue in ALS. Acta Myol (2011) 1.31
Evidence that microglia mediate the neurobiological effects of chronic psychological stress on the medial prefrontal cortex. Cereb Cortex (2011) 1.30
Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett (2001) 1.30
Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness. Pharmacol Rep (2008) 1.29
IL-6 production by rat peritoneal mast cells is not necessarily preceded by histamine release and can be induced by bacterial lipopolysaccharide. J Immunol (1994) 1.29
Inflammasome signaling at the heart of central nervous system pathology. J Neurosci Res (2010) 1.28
Behavioral phenotypes of mice lacking purinergic P2X4 receptors in acute and chronic pain assays. Mol Pain (2009) 1.27
Effects of palmitoylethanolamide on release of mast cell peptidases and neurotrophic factors after spinal cord injury. Brain Behav Immun (2011) 1.27
Regulation of the genes encoding interleukin-6, its receptor, and gp130 in the rat brain in response to the immune activator lipopolysaccharide and the proinflammatory cytokine interleukin-1beta. J Neurochem (1997) 1.26
TLR4 mutation reduces microglial activation, increases Aβ deposits and exacerbates cognitive deficits in a mouse model of Alzheimer's disease. J Neuroinflammation (2011) 1.26
Identification of new ANG gene mutations in a large cohort of Italian patients with amyotrophic lateral sclerosis. Neurogenetics (2007) 1.25
Massive accumulation of N-acylethanolamines after stroke. Cell signalling in acute cerebral ischemia? J Neurochem (2004) 1.24
Characterization of functional vanilloid receptors expressed by mast cells. Blood (1998) 1.21
Cerebral mast cells regulate early ischemic brain swelling and neutrophil accumulation. J Cereb Blood Flow Metab (2006) 1.21
Activation of Src-family kinases in spinal microglia contributes to mechanical hypersensitivity after nerve injury. J Neurosci (2006) 1.20
N-palmitoyl-ethanolamine: Biochemistry and new therapeutic opportunities. Biochimie (2010) 1.19
Mast cells as early responders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab (2010) 1.19
Acute intracerebroventricular administration of palmitoylethanolamide, an endogenous peroxisome proliferator-activated receptor-alpha agonist, modulates carrageenan-induced paw edema in mice. J Pharmacol Exp Ther (2007) 1.18
Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J (2012) 1.18
A quantitative study of microglial-macrophage synthesis of tumor necrosis factor during acute and late focal cerebral ischemia in mice. J Cereb Blood Flow Metab (2005) 1.18
Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients. Ann Neurol (1995) 1.18
Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia. Eur J Pharmacol (2009) 1.14
Palmitoylethanolamide, a naturally occurring disease-modifying agent in neuropathic pain. Inflammopharmacology (2013) 1.61
MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease. J Biol Chem (2006) 1.20
Microglia and mast cells: two tracks on the road to neuroinflammation. FASEB J (2012) 1.18
Abeta(1-42) reduces synapse number and inhibits neurite outgrowth in primary cortical and hippocampal neurons: a quantitative analysis. J Neurosci Methods (2008) 1.04
P2X(7) receptors on microglial cells mediate injury to cortical neurons in vitro. Glia (2006) 1.02
Mast cells, glia and neuroinflammation: partners in crime? Immunology (2014) 0.99
Endocannabinoids in nervous system health and disease: the big picture in a nutshell. Philos Trans R Soc Lond B Biol Sci (2012) 0.96
Glia and mast cells as targets for palmitoylethanolamide, an anti-inflammatory and neuroprotective lipid mediator. Mol Neurobiol (2013) 0.95
MAP kinase pathways in neuronal cell death. CNS Neurol Disord Drug Targets (2008) 0.93
Neuroinflammation, microglia and mast cells in the pathophysiology of neurocognitive disorders: a review. CNS Neurol Disord Drug Targets (2014) 0.91
Identification of neuroprotective properties of anti-MAG antibody: a novel approach for the treatment of stroke? J Cereb Blood Flow Metab (2005) 0.89
N-Palmitoylethanolamine and Neuroinflammation: a Novel Therapeutic Strategy of Resolution. Mol Neurobiol (2015) 0.86
A dimeric version of the short N-cadherin binding motif HAVDI promotes neuronal cell survival by activating an N-cadherin/fibroblast growth factor receptor signalling cascade. Mol Cell Neurosci (2004) 0.81
Astrocyte-microglia cooperation in the expression of a pro-inflammatory phenotype. CNS Neurol Disord Drug Targets (2013) 0.81
Oligodendrocytes are a novel source of amyloid peptide generation. Neurochem Res (2009) 0.80
Apoptosis-associated tyrosine kinase and neuronal cell death. Neurochem Res (2009) 0.78
TASTPM mice expressing amyloid precursor protein and presenilin-1 mutant transgenes are sensitive to γ-secretase modulation and amyloid-β₄₂ lowering by GSM-10h. Neurodegener Dis (2010) 0.77
Central nervous system neuron-glia co-culture models. Methods Mol Biol (2012) 0.76
Reply to: "Palmitoylethanolamide: problems regarding micronization, ultra-micronization and additives" Inflammopharmacology DOI:10.1007/s10787-014-0202-3. Inflammopharmacology (2014) 0.75
[³H]serotonin release assay using antigen-stimulated rat peritoneal mast cells. Methods Mol Biol (2012) 0.75
Intracellular ion channel CLIC1: involvement in microglia-mediated β-amyloid peptide(1-42) neurotoxicity. Neurochem Res (2013) 0.75
Culture and characterization of rat mesencephalic dopaminergic neurons. Methods Mol Biol (2012) 0.75